Article
Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
Molecular therapy : the journal of the American Society of Gene Therapy - 2 Aug 2017
Beltran William A, Cideciyan Artur V, Boye Shannon E, Ye Guo-Jie, Iwabe Simone, Dufour Valerie L, Marinho Luis Felipe, Swider Malgorzata, Kosyk Mychajlo S, Sha Jin, Boye Sanford L, Peterson James J, Witherspoon C Douglas, Alexander John J, Ying Gui-Shuang, Shearman Mark S, Chulay Jeffrey D, Hauswirth William W, Gamlin Paul D, Jacobson Samuel G, Aguirre Gustavo D
Abstract excerpt
X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene is an early onset and severe cause of blindness. Successful proof-of-concept studies in a canine model have recently shown that development of a corrective gene therapy for RPGR-XLRP may now be an attainable goal. In preparation for a future clinical trial, we have here optimized the therapeutic AAV vector construct by showing that GRK1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
